Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DC72634 | (Rac)-SNC80 |
(Rac)-SNC80 is a racemate of SNC80. SNC80 (NIH 10815) is a potent, highly selective and non-peptide δ-opioid receptor agonist with a Ki of 1.78 nM and an IC50 of 2.73 nM. SNC80 shows antinociceptive, antihyperalgesic and antidepressant‐like effects. SNC80 has the potential for multiple headache disorders treatment.
More description
|
![]() |
DC44976 | LY2940094 tartrate Featured |
LY2940094 (BTRX-246040) tartrate is a potent, brain penetrant, selective and orally available N/OFQ peptide (NOP) receptor antagonist with high affinity (Ki=0.105 nM) and antagonist potency (Kb=0.166 nM). LY2940094 tartrate reduces Ethanol self-administration and Ethanol seeking in animal models.
More description
|
![]() |
DC74621 | Icalcaprant |
Icalcaprant is a kappa-opioid receptor antagonist.
More description
|
![]() |
DC73479 | ZYKR1 |
ZYKR1 is a potent, and peripherally restricted kappa opioid receptor (KOR)-selective agonist with EC50 of 0.061 nM in cAMP assays, highly selective over the mu and delta opioid receptors (EC50>10 μM).
More description
|
![]() |
DC73478 | PN6047 |
PN6047 is an orally bioavailable, G protein-biased and selective δ opioid agonist with pKi of 7.25, fully engages G protein signaling but is a partial agonist in both the arrestin recruitment and internalization assays.
More description
|
![]() |
DC73477 | PIPE-3297 |
PIPE-3297 is a fully efficacious and selective kappa opioid receptor (KOR) agonist with functional GTPγS EC50 of 1.1 nM, Emax=91%, does not elicit β-arrestin-2 recruitment functional response.
More description
|
![]() |
DC73476 | Naltrexone hydrochloride |
A potent, competitive antagonist for μ, κ, δ, and σ-opioid receptors with Ki of 0.0825 nM, 0.509 nM, and 8.02 nM, for MOR, KOR, and DOR, respectively.
More description
|
![]() |
DC73475 | MP135 |
MP135 is a potent, μ-δ opioid receptor heteromer-selective agonist with EC50 of 0.8 nM in GTPγS assays, shows functional selectivity for μ-δ heteromers over homomeric μOR and δOR and low β-arrestin2 recruitment activity.
More description
|
![]() |
DC73474 | LY2817412 |
LY2817412 is a potent, selective andorally active nociceptin/orphanin FQ (NOP) receptor antagonist with Ki of 0.176 nM, Kb of 0.273 nM in functional assay of receptor-mediated G-protein activation using [35S]-GTPγS binding.
More description
|
![]() |
DC73473 | AT-039 |
AT-039 is a potent, selective agonist of nociceptin opioid peptide (NOP) receptor, AT-039 is useful for treatment of hypertension and/or volume overload/hyponatraemic states.
More description
|
![]() |
DC46693 | DAMGO Featured |
DAMGO (DAGO) is a potent and selective μ opioid receptor agonist with ki of 17 nM.
More description
|
![]() |
DC48169 | DS34942424 Featured |
DS34942424 is an orally potent analgesic without mu opioid receptor agonist activity.
More description
|
![]() |
DC42314 | EST73502 Featured |
EST73502 is a selective, orally active and blood-brain barrier (BBB) penetrant dual μ-opioid receptor (MOR) agonist and σ1 receptor (σ1R) antagonist, with Kis of 64 nM and 118 nM for MOR and σ1R, respectively. EST73502 has antinociceptive activity.
More description
|
![]() |
DC72633 | Naloxonazine |
Naloxonazine is a potent and selective opiate mu-1 antagonist that can also affect leishmania by regulating host coding function.
More description
|
![]() |
DC72632 | (S,S)-J-113397 |
(S,S)-J-113397 is an isomer of J-113397. J-113397 is an Opioid Receptor antagonist.
More description
|
![]() |
DC8626 | Eluxadoline Featured |
Eluxadoline is an orally active mixed μ opioid receptor (μOR) agonist δ opioid receptor (δOR) antagonist.
More description
|
![]() |
DC9765 | CERC-501(LY-2456302,Aticaprant) Featured |
CERC-501(LY-2456302) is a potent, selective antagonist of the kappa opioid receptor (KOR) (Ki = 0.81 nM vs. 24.0 nM and 155 nM for the μ-opioid receptor (MOR) and δ-opioid receptor (DOR), respectively.
More description
|
![]() |
DC7097 | Cebranopadol(GRT-6005) Featured |
branopadol(GRT-6005) is a novel first in class compounds with potent agonist activity on ORL-1 (opioid receptor like -1) and the well established mu opioid receptor.
More description
|
![]() |
DC8298 | BAN ORL 24 Featured |
BAN ORL 24 is a potent, selective, competitive ORL1 non-peptide agonist. Displays 1000-fold selectivity over classical opioid receptors.
More description
|
![]() |
DC7050 | ADL5859 HCl Featured |
ADL5859 agonizes δ-opioid receptor with a 1000-fold selectivity than µ- or κ-opioid receptor with Ki of 32 nM and 37 nM, respectively.ADL5859 displays weak inhibitory activity at the hERG channel with an IC50 of 78 μM. The EC50 of ADL5859 against δ opioid
More description
|
![]() |
DC72344 | NAQ |
NAQ is a potent and selective μ opioid receptor partial agonist, with a Ki of 0.55 nM. NAQ shows selectivity for Mu opioid receptor over the δ receptor (Ki=132.50 nM) and the κ receptor (Ki=26.45 nM). NAQ can be used for the research of opioid withdrawal or dependence.
More description
|
![]() |
DC72343 | ZP 120C |
ZP 120C is a potent and partial ORL1 receptor agonist. ZP 120C inhibits electrically induced contraction. ZP 120C can be used in the research of hyponatremia/hypokalemia.
More description
|
![]() |
DC41767 | Nociceptin(1-7) TFA |
Nociceptin (1-7) TFA is the N-terminal bioactive fragment of nociceptin. Nociceptin (1-7) TFA is a potent ORL1 (NOP) receptor agonist with antinociceptive activity. Nociceptin (1-7) TFA combines with nociceptin reduces hyperalgesia in vivo.
More description
|
![]() |
DC41766 | Nociceptin(1-7) |
Nociceptin (1-7) is the N-terminal bioactive fragment of nociceptin. Nociceptin (1-7) is a potent ORL1 (NOP) receptor agonist with antinociceptive activity. Nociceptin (1-7) combines with nociceptin reduces hyperalgesia in vivo.
More description
|
![]() |
DC40982 | Loperamide phenyl |
Loperamide phenyl is an impurity of Loperamide. Loperamide is an opioid receptor agonist.
More description
|
![]() |
DC71526 | [Leu5]Enkephalin |
[Leu5]Enkephalin a five amino acid endogenous peptide that acts as an agonist at opioid receptors.
More description
|
![]() |
DC71348 | SNC162 |
SNC162 is a delta-opioid receptor agonist with an IC50 of 0.94 nM. SNC162 has antidepressant-like effects and produces a selective enhancement of the antinociceptive effects of fentanyl in rhesus monkeys.
More description
|
![]() |
DC71347 | BW373U86 |
BW373U86 (SNC86) is a δ-opioid receptor agonist with an IC50 of 1.49 nM. BW373U86 shows antidepressant-like effects.
More description
|
![]() |
DC70967 | Eptazocine |
Eptazocine (Sedapain) is a κ-opioid receptor agonist and μ-opioid receptor antagonist. Eptazocine has the effect of relieving pain.
More description
|
![]() |
DC70882 | VISTA inhibitor M351-056 |
VISTA inhibitor M351-056 is a small molecule compound having affinity with VISTA.
More description
|
![]() |